findmyKOL
Clinical trialNCT01241318CompletedPhase 2/PHASE3Interventional

Zambia Chlorhexidine Application Trial

SponsorBoston UniversityEnrollment77,535Sepsis
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

  • Davidson H Hamer, MD

    Boston University Center for Global Health and Development

    Principal Investigator
  • Katherine Semrau, PhD

    Boston University Center for Global Health and Development

    Principal Investigator

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Zambia
  • Facilities Throughout Southern Province

    Choma, Southern Province, Zambia

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
28 Feb 2011
Primary completion
30 Sept 2013
Completion
30 Sept 2013
Last update posted
31 Aug 2020
Registered enrollment
77,535
Registry id
NCT01241318

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.